Aeolus Pharmaceuticals Receives $175,000 Milestone Payment From Cardiovascular Company.
Business Wire › October 01, 2008
Linked as:
Extract
Aeolus Pharmaceuticals Receives $175,000 Milestone Payment From Cardiovascular Company.
New Drug Application (NDA) for Bucindolol in the Treatment of Chronic Heart Failure Accepted by the U.S. Food and Drug Administration
Bucindolol Has Been Shown to Significantly Reduce Hospitalizations and Deaths in Heart Failure Patients with a Specific, Common Genetic Variation in a Phase III Clinical Study LAGUNA NIGUEL, Cal...See the full content of this document
Sponsored links
